In human colon cancer cells, IGF-I stimulates β-catenin relocation and stability through the inactivation of GSK-3β, which increases cell motility and contributes to colon cancer metastasis [94, 95]. This evidence concerns the gene IGF1 and malignant colon neoplasm.